Researchers Unveil HIV Persistence & Reservoirs Meeting Advanced Program 

by Star One Public Relations Friday, April 08, 2011
Toulon, France - April 08, 2011 -- Despite major improvements in life expectancy and quality of life with antiretroviral therapy, today’s treatment cannot cure HIV infection. To try to eradicate HIV from infected individuals, researchers must figure out where the virus hides and how persistent infection is established in these sites. They have also to screen and test new kinds of drugs able to reach HIV in its ‘dormant’ state.

The prospect of efficiently controlling HIV persistence in infected persons without permanent antiretroviral therapy is the hard task a group of researchers has addressed since 2003. By organizing every 2-year the “International Workshop on HIV Persistence, Reservoirs & Eradication Strategies”, they sum-up their current advances in the field.

The Steering Committee has just announced the preliminary program of the next edition of the workshop, to be held December 6-9, 2011.

Understanding the mechanisms of HIV persistence implies molecular biologists, virologist and immunologists to work together. Then, this leads to new strategies that are implemented by clinical researchers. This preliminary program therefore includes top researchers from these different areas, coming from USA, Europe and Australia. These 3 days meeting will go from the animal models of HIV persistence to the currently ongoing trials of gene therapy. It will combine state-of-the-art presentations, un-published data submitted by participants, and extended time for discussion.

The previous workshops have been very successful with more than 150 top class scientists from all across the globe attending it. The workshop is an excellent opportunity for these delegates to interact and share information with other researchers, governmental agencies, patients representatives and pharmaceutical companies.

About the Workshop:
The top scientists who have devoted their efforts to this workshop include: Alain Lafeuillade, Department of Infectious Diseases, General Hospital, Toulon, France, José Alcami, AIDS Immunopathology Unit, Institute of Health "Carlos III", Madrid, Spain; Monsef Benkirane, CNRS, Laboratory of Molecular Biology, Montpellier, France; Nicolas Chomont, Vaccine & Gene Therapy Institute, Port Ste Lucie, FL, USA; Tae-Wook Chun from the National Institute of Allergy and Infectious Diseases, Bethesda, USA; David Margolis, University of North Carolina, Chapell Hill, USA; Robert Gallo from The Institute of Human Virology, Baltimore, USA; Marie-Lise Gougeon, Antiviral Immunity, Biotherapy & Vaccine Unit, Pasteur Institute, Paris, France; Mario Stevenson from the University of Miami - Miller School of Medicine, Miami, USA; and François Barré-Sinoussi, Pasteur Institute, Paris, France, 2008 Nobel Laureate for Medicine.

Alain Lafeuillade
General Hospital
Toulon, France
Ph: +33-4-94616340

0    submitted by Star One Public Relations
Read More Press Releases

Thanks to robots, company registration in Singapore has become cheaper

Koincable Introduces Four Customizable HDMI Cables

SKS Ispat& Power Ltd commissions first 300-MW power unit of their 1,200-MW RaigarhPower Plant

How a Bodybuilding Diet Can Help Build Muscle Naturally

Low Carb Diet Report Casts Light On New Research Findings

Increase in the number of student visa is trending nowadays

Wiwigo Technologies: First of its kind selfie campaign takes place in moving Delhi-Chandigarh Shatabdi

An important day in real estate sector

Leonard Kim to Appear on Critical Mass Radio Show

Nishan Kohli's recent exhibition on photography

Get press releases by email